Author:
Mkuhlu Nwabisa Azisa,Chuks Iweriebor Benson,Chikwelu Obi Larry
Abstract
Objectives:
Developing countries like South Africa are still faced with numerous challenges such as poor environmental sanitation, lack of clean drinking water and inadequate hygiene which have contributed largely to diarrheal infections and deaths in children. This study was aimed at investigating the prevalence of pathotypes, antimicrobial resistance and drug resistance determinants among Escherichia coli (E. coli) isolates from diarrhea stool samples within Buffalo City Municipality, Eastern Cape, South Africa.
Methods:
Fresh diarrheal stool samples were collected from 140 patients attending public health centres within the Municipality and presumptive E. coli isolates were obtained from the stool samples using E. coli chromogenic agar while PCR amplification methods were used to confirm the presumptive isolates as well as delineate them into pathotypes based on the presence of certain virulence genes. In addition, antimicrobial susceptibility and screening of some of the antimicrobial resistant determinants were performed on all the confirmed isolates.
Results:
A total of 394 presumptive E. coli isolates from 140 diarrhea stool samples were subjected to polymerase chain reaction amplification, of which 265 were confirmed positive as E. coli. Pathotypes delineation of the positive E. coli isolates validated the presence of ETEC 106 (40%), EAEC 48 (18%), DAEC 37 (14%), and EPEC 31 (11%) while no EIEC pathotype was detected. All E. coli isolates exhibited maximum susceptibility to gentamicin (95%), amikacin (91%), nitrofurantoin (91%), meropenem (90%), chloramphenicol (91%) norfloxacin (84%) and imipenem (83%). However, the isolates showed multidrug resistance to penicillin G, ampicillin, trimethoprim, tetracycline, doxycycline, and erythromycin, with over 71% of the isolates resistant to the drugs. The prevalence and distribution of the five resistance determinants assessed were as follow; sulphonamides; sulII (12%), beta lactams; [ampC (22%); blaTEM, (25%)], and tetracyclines (tetA (35%).
Conclusion:
The results from this study suggest the probable involvement of E. coli pathotypes as an etiologic agent of diarrhea in the study area and revealed high levels of multidrug resistance among the isolates, which could be a major health burden.
Publisher
Bentham Science Publishers Ltd.
Subject
General Immunology and Microbiology
Reference51 articles.
1. CDC.
2017.
https://www.cdc.gov/healthywater/hygiene/disease/ chronic_diarrhea.html
2. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhea in 195 countries: A systematic analysis for the Global Burden of Disease Study 2016.
Lancet Infect Dis
2016;
2018
(18)
: 1211-28.
3. Awotiwon OF, Wyk VP, Dhansay A, Day C, Bradshaw D.
Diarrhea in children under five years of age in South Africa (1997–2014).
Trop Med Int Health
2016;
21
(9)
: 1060-70.
4. Rudan I, Nair H, Marušić A, Campbell H.
Reducing mortality from childhood pneumonia and diarrhea: The leading priority is also the greatest opportunity.
J Glob Health
2013;
3
(1)
5. Liu L, Oza S, Hogan D, et al.
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis.
Lancet
2015;
385
(9966)
: 430-40.